147 results
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:23am
or exchange;
ranking;
restrictive covenants, if any;
voting or other rights, if any; and
important U.S. federal income tax considerations … amounts of the debt securities of the series to any holder that is not a “United States person” for federal tax purposes;
any restrictions on transfer
8-K
EX-1.1
AQST
Aquestive Therapeutics Inc
21 Mar 24
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
and foreign income and franchise tax returns and has paid all taxes required to be filed or paid by it and, if due and payable, any related or similar … taxes for all periods as to which the tax liability of the Company has not been finally determined. The Company is not aware of any material claims
424B5
wdkpt66e
21 Mar 24
Prospectus supplement for primary offering
4:06pm
424B5
tqaq2h0plj3bopd 718
19 Mar 24
Prospectus supplement for primary offering
5:18pm
8-K
EX-99.1
4e8se
5 Mar 24
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
5:09pm
8-K
EX-99.1
fwub54p
6 Nov 23
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results
5:20pm
8-K
EX-10.1
ydf apapp
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.2
a1dk3
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.3
x1w2 hg71adv17
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-4.1
60ppgyamz n5
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
S-8
EX-4.1
480cz
9 Aug 23
Registration of securities for employees
5:22pm
8-K
EX-99.1
44z6c3
7 Aug 23
Results of Operations and Financial Condition
5:08pm
8-K
EX-4.1
9y4n15x8y2fdp lr
2 Aug 23
Entry into a Material Definitive Agreement
8:22am